NanoBio(R) Corporation Initiates Phase 2b Clinical Trial For Herpes Labialis Treatment
Fri, 16 Feb 2007 08:00 AM EST
... NanoBio(R) Corporation, a biopharmaceutical company developing novel products for the treatment and prevention of topical infections, today announced that it has begun enrolling patients in its Phase 2b study of NB-001, a drug candidate for the topical treatment of Herpes labialis. [click link for full article] ...
Related Topics
- Clinical Trials
- Herpes
- Genital Herpes
- Zoster
- Herpes Simplex
- Shingles
- Ribavirin and Interferon alfa-2b, recombinant
- Pharmacology
- Pancreatic Cancer
- Trastuzumab
- Psychopharmacology
- Interferon Alfa-2b
- Crohn's Disease
- Tarceva
- Shingles (Herpes Zoster)
- Peginterferon alfa-2b
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Depression
- Western/Clinical Treatment and Therapy

Not Signed In -


